波士顿科学节拍收入估计数为0.75美元EPS和5.07B收入,上升了20.3%Yoy,提高了其股票和市场上限。 Boston Scientific beat earnings estimates with $0.75 EPS and $5.07B revenue, up 20.3% YoY, boosting its stock and market cap.

波士顿科学公司报告说,第三季度成绩强劲,收入为7.5 EPS和50.7亿美元,超过估计数,年收入增长20.3%。 Boston Scientific Corp. reported strong third-quarter results with $0.75 EPS and $5.07 billion in revenue, surpassing estimates, driven by a 20.3% year-over-year revenue increase. 机构投资者,包括Trek Finance、Jennison Associates和UniSuper等机构投资者增加了其股份,而Resona资产管理公司则减少了其持有量。 Institutional investors, including Trek Financial, Jennison Associates, and UniSuper, increased their stakes, while Resona Asset Management reduced its holding. 股价升至92.56美元,市场上限为1 372.2亿美元,P/E比率为49.50,以及“多价购买”分析师的共识评级。 The stock rose to $92.56, with a market cap of $137.22 billion, a P/E ratio of 49.50, and a "Moderate Buy" analyst consensus rating.